Background illustration for clinical trials search

Paid Clinical Trials Tennessee

Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

for
Cardiovascular Disease and Lipoprotein(a)
Location: Scarborough ME, Boston MA, Riverhead NY, Hartford CT,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07517263

Phase3, Recruiting

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

for
Follicular Lymphoma (FL)
Location: Saint John, Boston MA, Quebec, Stony Brook NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06091254

Phase3, Recruiting

Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage

for
End Stage Chronic Renal Failure,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18+

Code: NCT07385651

Recruiting

A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1

for
HIV
Location: Philadelphia PA, Birmingham AL, Nashville TN,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 55

Code: NCT07390955

Phase1, Recruiting

Abbott Cephea Mitral Valve Disease Registry

for
Mitral Regurgitation, Mitral Stenosis, Mitral Valve Disease,
Location: Roslyn NY, The Bronx NY, Norfolk VA, Charleston SC,
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT07069673

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

for
Multiple Myeloma, Newly Diagnosed, Multiple Myeloma (MM)
Location: Norfolk VA, Chapel Hill NC, Columbus OH, Birmingham AL,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 19+

Code: NCT06974786

Phase2, Recruiting

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

for
Esophageal Squamous Cell Carcinoma
Location: Brooklyn NY, Morristown NJ, Hershey PA, Fairfax VA,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06644781

Phase3, Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Boston MA, New York NY, Cleveland OH, Grand Rapids MI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06465069

Phase1, Recruiting

Neonatal Platelet Transfusion Threshold Trial

for
Thrombocytopenia, Neonatal, Platelet Transfusion,
Location: Boston MA, Philadelphia PA, Rochester NY, Durham NC,
Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 0

Code: NCT06676904

Recruiting

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

for
T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: New York NY, Philadelphia PA, Norfolk VA,
Sponsor: Allotera Therapeutics

Sex: All

Age: 0+

Code: NCT06514794

Phase2, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Sydney, Halifax, Bridgewater, Bangor ME, Scarborough ME,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

E-Mindfulness Approaches for Living After Breast Cancer

for
Breast Cancer, Depression
Location: Gloucester MA, Beverly MA, Peabody MA, Boston MA,
Sponsor: NRG Oncology

Sex: All

Age: 18 - 50

Code: NCT06748222

Phase3, Recruiting

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

for
Renal Cell Carcinoma, Urothelial Carcinoma,
Location: Boston MA, Philadelphia PA, Cleveland OH, Ann Arbor MI,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06966024

Phase1, Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

for
Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic,
Location: Quebec, Bethesda MD, Richmond VA, West Palm Beach FL,
Sponsor: Loxo Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05254743

Phase3, Recruiting

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis
Location: Foxborough MA, New Haven CT, New York NY, Totowa NJ,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07039916

Phase3, Recruiting

Rapid Evacuation and Access of Cerebral Hemorrhage Trial

for
Stroke Hemorrhagic
Location: Providence RI, Albany NY, Baltimore MD, Syracuse NY,
Sponsor: Emory University

Sex: All

Age: 18 - 70

Code: NCT06870812

Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for
Prostate Cancer (Adenocarcinoma)
Location: Saint John, Providence RI, Saint Johnsbury VT,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase3, Recruiting

Revealing Information Genuinely & Honestly Across Time - Communication Preferences Visit

for
Cancer, Communication
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 12+

Code: NCT06993688

Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for
Somatostatin Receptor Positive (SSTR+),
Location: Hartford CT, New Haven CT, New York NY, Montreal,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase3, Recruiting

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

for
Lymphoma, Lymphoma, Non Hodgkin
Location: New York NY, Philadelphia PA, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07082803

Phase1, Recruiting

Popular cities in Tennessee

MurfreesboroChattanoogaKnoxvilleNashvilleMemphis